Randomised Olmesartan and Diabetes Microalbuminuria Prevention Study

Update Il y a 4 ans
Reference: EUCTR2004-000506-52

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To determine the difference in the time to event of microalbuminuria in patients receiving 40 mg olmesartan medoxomil compared to placebo using morning spot urine collections, assessed from baseline until occurrence of microalbuminuria.


Inclusion criteria

  • NIDDM (non insulin dependent diabetes mellitus)